New FDA 510(k) Clearance Expands Bayer’s MEDRAD® MRXperion MR Injection System Support Across Diverse Range of MR Environments

Bayer today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for expanded capabilities of ...
Medical Device Network

Bayer secures expanded FDA clearances for MRI contrast agent injector

The FDA's expanded clearances broaden the application of Bayer's Medrad MRXperion system across a wider range of MR settings.

New imaging technique could transform precision of vocal fold injection procedures

Researchers at Stanford University, in collaboration with scientists at the German Cancer Institute, have shown for the first ...
BioSpace

New indication in pediatric patients, including term neonates for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) Injection

Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with the highest relaxivity, in comparison to other availab ...